Generic Animal Drug Alliance

The Alliance monitors activities of fda regulatory & legislative bodies and provides information on topics of fda regulatory affairs, legislative issues, pharmaceutical technology and current good manufacturing practices (cgmp) compliance to member companies through newsletters and mailings. The Alliance also represents interests of the Generic Animal Drug industry before the fda and other regulatory bodies, and in doing so, it speaks with the strength of a coalition of companies. The Alliance has established numerous scientific and cgmp compliance review committees that provide comments in response to fda proposals. The Alliance monitors the Generic Animal Drug approval process with the fda.